Sign in
Not yet recruitingNo phase

Phone app to help manage blood clots in veins

Tests a phone app for preventing venous thromboembolism in adults at high risk.

Key facts

Who runs it
Navy General Hospital, Beijing
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
Smart Technology Facilitated Patient-centered Venous Thromboembolism Management
Status
Not yet recruiting
People taking part
2,353 people, planned
Started
1 Nov 2024
Expected to end
31 Oct 2027
Type of study
Interventional
Treatments tested
  • mobile venous thromboembolism application (mVTEA)
Record updated
17 July 2024

Who can take part

The trial is looking for adults in hospital who have a high risk of blood clots in the veins (VTE) when they go home. They will use a phone app to help manage this risk.

Age
18 years and older at admission.
Sex
All sexes.
Disease stage
High risk of VTE at discharge: Padua score ≥4 for medical patients, or Caprini score ≥5 for surgical patients.
Main reasons for not taking part
  • Diagnosed with VTE at discharge.
  • Mental disorder or other serious disease that stops you from living on your own.
  • Unable to use smartphones, tablets or other smart devices.
  • Pregnant or breastfeeding.
  • Took part in similar trials before, or now in another clinical trial.
Show the full registry criteria (8)Hide the full registry criteria

Who can take part

  • Inpatients ≥18 years of age at admission
  • At high-risk of VTE at discharge: Padua score ≥4 for medical patients and Caprini score ≥5 for surgical patients
  • Signed informed consent

Who cannot take part

  • Mental disorder or combination of other serious diseases leading to incapacity for independent living
  • Diagnosis of VTE at discharge
  • Inability to use smartphones, computer tablets and other smart devices
  • Being pregnant or breastfeeding
  • Have participated in similar trials or are undergoing other clinical trials

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Venous thromboembolism or digital health or health education

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Smart technologies, such as wearable devices, mobile technologies, and artificial intelligence, are being investigated for use in health management. These technologies have the potential to be applied in disease pre-warning, decision-making support, health education, and healthcare maintenance. They are expected to address the challenges in managing thrombosis, improve access to high-quality medical resources in various regions, and enhance the development of a network for thrombosis rescue and treatment prevention.

Read full original descriptionShow less

The objective of this study is to observe the long-term effect of mobile venous thromboembolism application (mVTEA) based patient-centered management of venous thromboembolism (VTE) on thromboprophylaxis, and establish a foundation of evidence for managing patients with high-risk VTE.

The group in the trial

  • mVTEA Management GroupTreatment being tested

    Patients with high-risk of VTE will be discharged with mVTEA-assisted patient-centered VTE management.

    Treatment: mobile venous thromboembolism application (mVTEA)

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Smart Technology Facilitated Patient-centered Venous Thromboembolism Management: A Multicenter Cohort Study
Plain-language title
Phone app to help manage blood clots in veinsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Criteria questions
Built from NCT06350344, who can take part
Record updated
17 July 2024